Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).

Lipshultz SE, Shearer WT, Thompson B, Rich KC, Cheng I, Orav EJ, Kumar S, Pignatelli RH, Bezold LI, LaRussa P, Starc TJ, Glickstein JS, O'Brien S, Cooper ER, Wilkinson JD, Miller TL, Colan SD.

J Am Coll Cardiol. 2011 Jan 4;57(1):76-85. doi: 10.1016/j.jacc.2010.08.620.

PMID:
21185505
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Height, weight, and growth in children born to mothers with HIV-1 infection in Europe.

Newell ML, Borja MC, Peckham C; European Collaborative Study.

Pediatrics. 2003 Jan;111(1):e52-60.

PMID:
12509595
[PubMed - indexed for MEDLINE]
3.

Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study.

Lipshultz SE, Williams PL, Wilkinson JD, Leister EC, Van Dyke RB, Shearer WT, Rich KC, Hazra R, Kaltman JR, Jacobson DL, Dooley LB, Scott GB, Rabideau N, Colan SD; Pediatric HIV/AIDS Cohort Study (PHACS).

JAMA Pediatr. 2013 Jun;167(6):520-7. doi: 10.1001/jamapediatrics.2013.1206.

PMID:
23608879
[PubMed - indexed for MEDLINE]
4.

Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.

Gibb DM, Kizito H, Russell EC, Chidziva E, Zalwango E, Nalumenya R, Spyer M, Tumukunde D, Nathoo K, Munderi P, Kyomugisha H, Hakim J, Grosskurth H, Gilks CF, Walker AS, Musoke P; DART trial team.

PLoS Med. 2012;9(5):e1001217. doi: 10.1371/journal.pmed.1001217. Epub 2012 May 15.

PMID:
22615543
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Reduced diastolic function and left ventricular mass in HIV-negative preadolescent children exposed to antiretroviral therapy in utero.

Cade WT, Waggoner AD, Hubert S, Krauss MJ, Singh GK, Overton ET.

AIDS. 2012 Oct 23;26(16):2053-8. doi: 10.1097/QAD.0b013e328358d4d7.

PMID:
22874520
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group.

Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT, Lai WW, Moodie DS, Sopko G, McIntosh K, Colan SD.

N Engl J Med. 2000 Sep 14;343(11):759-66.

PMID:
10984563
[PubMed - indexed for MEDLINE]
Free Article
7.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
[PubMed - indexed for MEDLINE]
8.

The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants.

Frederick T, Homans J, Spencer L, Kramer F, Stek A, Operskalski E, Kovacs A.

Clin Infect Dis. 2012 Sep;55(6):877-84. doi: 10.1093/cid/cis535. Epub 2012 Jun 6.

PMID:
22675157
[PubMed - indexed for MEDLINE]
Free Article
9.

Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers.

Bunders MJ, Bekker V, Scherpbier HJ, Boer K, Godfried M, Kuijpers TW.

Acta Paediatr. 2005 Nov;94(11):1571-7.

PMID:
16303696
[PubMed - indexed for MEDLINE]
10.

A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.

Alimenti A, Forbes JC, Oberlander TF, Money DM, Grunau RE, Papsdorf MP, Maan E, Cole LJ, Burdge DR.

Pediatrics. 2006 Oct;118(4):e1139-45. Epub 2006 Aug 28.

PMID:
16940166
[PubMed - indexed for MEDLINE]
Free Article
11.

No relation between in-utero exposure to HAART and intrauterine growth retardation.

Briand N, Mandelbrot L, Le Chenadec J, Tubiana R, Teglas JP, Faye A, Dollfus C, Rouzioux C, Blanche S, Warszawski J; ANRS French Perinatal Cohort.

AIDS. 2009 Jun 19;23(10):1235-43. doi: 10.1097/QAD.0b013e32832be0df.

PMID:
19424054
[PubMed - indexed for MEDLINE]
12.

[Why are HIV-infected infants still being born in Spain?].

Fernández-Ibieta M, Ramos Amador JT, Guillén Martín S, González-Tomé MI, Navarro Gómez M, Iglesias González-Nicolás E, Rubio Gribble B, de José Gómez MI, Beceiro Mosquera J, Regidor J, De Santos Butragueño MJ, Martínez Guardia N, Roa Francia MA.

An Pediatr (Barc). 2007 Aug;67(2):109-15. Spanish.

PMID:
17692255
[PubMed - indexed for MEDLINE]
Free Article
13.

Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.

Palombi L, Marazzi MC, Voetberg A, Magid NA.

AIDS. 2007 Jul;21 Suppl 4:S65-71.

PMID:
17620755
[PubMed - indexed for MEDLINE]
14.

Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.

Bhargav H, Huilgol V, Metri K, Sundell IB, Tripathi S, Ramagouda N, Jadhav M, Raghuram N, Ramarao NH, Koka PS.

J Stem Cells. 2012;7(3):127-53. doi: jsc.2012.7.3.127.

PMID:
23619381
[PubMed - indexed for MEDLINE]
15.

Cardiovascular outcomes of pediatric seroreverters perinatally exposed to HAART: design of a longitudinal clinical study.

Lavigne JE, Shearer WT, Thompson B, Orav EJ, Starc TJ, Colan SD, Pignatelli R, O'Brien SE, Bezold L, LaRusa P, Easley KA, Cheng I, Duffy SA, Lipshultz SE; CHAART Study Group.

Cardiovasc Toxicol. 2004;4(2):187-97.

PMID:
15371634
[PubMed - indexed for MEDLINE]
16.

Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants.

Feiterna-Sperling C, Weizsaecker K, Bührer C, Casteleyn S, Loui A, Schmitz T, Wahn V, Obladen M.

J Acquir Immune Defic Syndr. 2007 May 1;45(1):43-51.

PMID:
17356471
[PubMed - indexed for MEDLINE]
17.

Perinatal exposure to antiretroviral therapy is associated with increased blood mitochondrial DNA levels and decreased mitochondrial gene expression in infants.

Côté HC, Raboud J, Bitnun A, Alimenti A, Money DM, Maan E, Costei A, Gadawski I, Diong C, Read S, Shen S, Harrigan PR, Burdge DR, King SM, Forbes JC.

J Infect Dis. 2008 Sep 15;198(6):851-9. doi: 10.1086/591253.

PMID:
18684095
[PubMed - indexed for MEDLINE]
Free Article
18.

Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana.

Powis KM, Smeaton L, Ogwu A, Lockman S, Dryden-Peterson S, van Widenfelt E, Leidner J, Makhema J, Essex M, Shapiro RL.

J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):131-8. doi: 10.1097/QAI.0b013e3181ffa4f5.

PMID:
21124227
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.

Williams PL, Marino M, Malee K, Brogly S, Hughes MD, Mofenson LM; PACTG 219C Team.

Pediatrics. 2010 Feb;125(2):e250-60. doi: 10.1542/peds.2009-1112. Epub 2010 Jan 18.

PMID:
20083530
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi.

Taha TE, Dallabetta GA, Canner JK, Chiphangwi JD, Liomba G, Hoover DR, Miotti PG.

Int J Epidemiol. 1995 Oct;24(5):1022-9.

PMID:
8557435
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk